SI-BONE’s studies focus on the iFuse implant for minimally invasive sacroiliac joint surgery. Here are five key notes about the partnership:
1. SI-BONE is sharing data from the Sacroiliac Joint Fusion With iFuse Implant System and plans to share data from two more trials over the next six months.
2. YODA is part of the Yale-New Haven Hospital Center for Outcomes Research and Evaluation and will have the “complete decision-making authority over the release of the data.” The independent academic partner will judge requests for the clinical data in the future.
3. The National Academy of Medicine recently recommended similar partnerships between industry and academia to share clinical research and inform the public. Setting these standards could raise the quality of evidence for healthcare decision-making.
4. YODA’s mission is to promote scientific inquiry while lowering barriers to accessing the data, and this partnership fits into that mission.
5. The company’s clinical studies demonstrate iFuse can improve pain, patient function and quality of life at one year after surgery. More than 20,000 iFuse procedures have been performed.
More articles on orthopedic devices:
4 trends in outpatient spine surgery from Amendia
Invibio settles with FTC over antitrust allegations: 7 key points
PODs under attack again: 5 key notes from the Senate Finance Committee’s report
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
